MCQs Quiz

Good Clinical Practice (GCP) in pharmacovigilance studies MCQs With Answer Good Clinical Practice (GCP) and pharmacovigilance are essential for safe, ethical clinical trials and post-marketing safety monitoring. This concise, student-focused introduction explains GCP principles, roles of sponsor, investigator, and ethics committee, adverse event (AE) and serious adverse event (SAE) reporting, SUSARs, signal detection, causality assessment, … Read more

Pharmacovigilance planning (ICH E2E) MCQs With Answer This concise introduction explains pharmacovigilance planning under ICH E2E for B. Pharm students. It covers pharmacovigilance system design, safety data collection, Individual Case Safety Reports (ICSRs), aggregate reporting (PBRER/PSUR), signal detection, risk management plans, benefit–risk assessment, expedited reporting timelines, and regulatory expectations. Emphasis is on practical topics: safety … Read more

Post-approval expedited reporting procedures MCQs With Answer — Introduction Post-approval expedited reporting procedures describe the fast-track processes that sponsors, investigators, and marketing authorization holders use to report serious and unexpected adverse events after a drug or device is authorized. For B. Pharm students, understanding expedited reporting is vital for pharmacovigilance, regulatory compliance, and patient safety. … Read more

Periodic Safety Update Report (PSUR) MCQs With Answer is a focused practice set designed for B.Pharm students to deepen understanding of pharmacovigilance, regulatory safety reporting, and post-marketing surveillance. This resource covers PSUR objectives, reporting timelines, data sources, adverse drug reaction analysis, risk-benefit assessment, and global guidance such as ICH principles and national regulatory requirements. Through … Read more

Individual Case Safety Reports (ICSRs) are the core documents used in pharmacovigilance to record suspected adverse drug reactions. This introduction highlights ICSR purpose, essential data elements (patient details, suspected product, adverse event, seriousness, outcome, batch/lot), regulatory standards such as ICH E2B, MedDRA coding, causality assessment methods, expedited timelines, and case follow-up. Understanding ICSR structure, data … Read more

Introduction: ICH expedited reporting requirements MCQs With Answer is a focused review designed for B. Pharm students studying pharmacovigilance and clinical safety. This concise guide explains key ICH concepts—such as SUSARs, SAEs, ICH E2A/E2B frameworks, timelines for expedited reports, ICSR elements, sponsor responsibilities, and follow‑up reporting—using practical multiple‑choice questions. Emphasis is placed on regulatory timelines … Read more

Introduction: The International Council for Harmonisation (ICH) is a global body that develops harmonized guidelines on quality, safety, efficacy and multidisciplinary topics to streamline pharmaceutical regulation and improve public health. B. Pharm students should understand ICH organization, guideline categories (Q, S, E, M), regulatory objectives, Common Technical Document (CTD), pharmacovigilance, quality systems (Q8–Q10), and drug … Read more

Introduction: Post-approval safety data generation and pharmacovigilance are essential components of drug lifecycle management for B. Pharm students. This topic covers post-marketing surveillance, adverse drug reaction (ADR) reporting, signal detection, risk management plans (RMP), Periodic Safety Update Reports (PSUR/PBRER), post-authorization safety studies (PASS), pharmacoepidemiology, spontaneous reporting systems, data mining (PRR, ROR), MedDRA coding, causality assessment, … Read more

Safety data collection in clinical phase studies is a core component of pharmacovigilance and drug development for B.Pharm students. This introduction covers essential keywords such as adverse events (AEs), serious adverse events (SAEs), SUSARs, case report forms (CRFs), MedDRA coding, electronic data capture (EDC), causality assessment, reporting timelines, data monitoring, and risk management. Understanding investigator … Read more

Safety data generation in the preclinical phase is essential for B. Pharm students to understand toxicology, pharmacokinetics (PK), ADME, and safety pharmacology. This topic covers design and conduct of in vitro and in vivo toxicity studies, dose selection, GLP principles, genotoxicity, reproductive toxicity, and toxicokinetics. Emphasis on data interpretation, risk assessment, regulatory requirements (ICH, OECD), … Read more